ELZA at the SCHWIND User Meeting 2025 in Bangkok
ELZA joined the SCHWIND User Meeting 2025 in Bangkok to share our insights on advanced laser eye surgery.
Mark Hillen
November 10, 2025
ELZA joined the SCHWIND User Meeting 2025 in Bangkok to share our insights on advanced laser eye surgery.
Nikki Hafezi expands K-MAP to Andijan, Uzbekistan, expanding keratoconus screening to the Fergana Valley.
We are proud to announce that ELZA Institute’s CEO, Nikki L. Hafezi MAS IP ETHZ, will serve as Course Director for a new international program in Uzbekistan — the “Professional Development Course in Visual Sciences and Public Health”.
Nikki Hafezi, MAS IP ETHZ led the P21 program in Bukhara, combining keratoconus screening with multidisciplinary pediatric assessments for 400 children.
In March 2025, Tashkent became the focal point for ophthalmology innovation as it hosted the Second International Conference on Innovative Technologies in Ophthalmology.
ELZA’s CEO, Nikki Hafezi launches a keratoconus screening initiative for children with Down syndrome in Uzbekistan, beginning in Andijan.
At EgSCRS, ELZA’s pyramid approach to keratoconus: ELZA-sub400, PACE, ECO-CAIRS, and AI-guided diagnostics was presented in detail.
As part of the 70th Anniversary celebration of the Andijan State Medical Institute (ASMI) in Uzbekistan, ELZA Institute CEO, Nikki Hafezi, MAS IP ETHZ, took part in a series of high-level academic and institutional events from April 28 to May 1, 2025.
Hafezi addressed the widespread reliance on a 1986 prevalence estimate that places keratoconus at 1 in 2,000—formally classifying it as rare. Yet as she highlighted, emerging epidemiological data tell a starkly different story. Keratoconus is an orphan disease, not a rare one.
During this visit to TOS 2025, Prof. Hafezi presented ECO-CAIRS and ELZA-PACE and highlighted the Light for Sight Foundation’s work to improve care for children with Down Syndrome.
